European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
No Result
View All Result
Home < INDUSTRIES Health

ABBOTT RECEIVES EUROPEAN AND CANADIAN APPROVAL FOR AMPLATZER™ STEERABLE DELIVERY SHEATH TO OPTIMIZE LEFT ATRIAL APPENDAGE CLOSURE PROCEDURES FOR PEOPLE AT RISK OF STROKE

by Alex Weber
June 8, 2021
A A
Share on LinkedinShare on Twitter

– First-of-its-kind steerable delivery system designed for left atrial appendage (LAA) occluder to seal the LAA in people who are at increased risk of stroke due to atrial fibrillation

– New delivery system works with Abbott’s leading Amplatzer Amulet™ LAA Occluder device to enable better access to the LAA and seals off a broad range of LAA anatomies

– Steerable sheath gives physicians enhanced flexibility and precise placement when implanting Amplatzer Amulet

ABBOTT PARK, Ill., June 7, 2021 — Abbott today announced it has received CE Mark and Health Canada approval for its Amplatzer™ Steerable Delivery Sheath, which is used with the company’s market-leading Amplatzer Amulet™ Left Atrial Appendage (LAA) Occluder. Now available in Europe and Canada, the new device is the first steerable delivery sheath that has been developed specifically for minimally invasive LAA occlusion (or closure) procedures to treat patients diagnosed with atrial fibrillation who are at risk of ischemic stroke.

Often referred to as AF or AFib, atrial fibrillation is the most common sustained cardiac arrhythmia. It occurs when the upper chambers of the heart (atria) beat out of coordination with the lower chambers (ventricles) and contract rapidly and irregularly. The LAA is a small pocket (or recess) connected to the upper left chamber of the heart that, in people with AF, can allow blood to pool and increase the likelihood of a clot forming and traveling to the brain to cause a stroke. For patients with AF who are unable to take blood thinning medication long term, physicians may perform closure procedures where the device is threaded through a vein in the leg and then implanted in the heart where it seals off the LAA, preventing blood clots from forming in the LAA and reducing the risk of stroke.1,2 

“Abbott’s Amplatzer Amulet has long been the LAA occlusion device of choice in Europe and Canada to reduce the risk of stroke and eliminate the need for blood thinning medication in patients with atrial fibrillation,” said Réda Ibrahim, M.D., Montréal Heart Institute, who completed one of the first global procedures with the new system. Jacqueline Saw, M.D., Vancouver General Hospital, who completed additional first procedures, added, “Physicians performing occlusion procedures on the LAA can now easily and precisely place the device in a broad range of anatomies with an enhanced delivery system that shortens procedure time and enhances efficiency.”

To improve physician ease-of-use, the Amplatzer Steerable Delivery Sheath features bi-directional steering and an “auto-lock” setting for more accurate alignment with the LAA. The sheath also includes a hemostasis valve designed to stabilize blood flow and minimize blood loss during the procedure. The new design additionally reduces the need for catheter manipulation or exchanges, which can slow down procedure time or cause further blood loss.

“This innovation advances the performance of our Amplatzer Amulet device and offers patients a much-needed treatment option to help manage stroke risk from atrial fibrillation,” said Michael Dale, senior vice president of Abbott’s structural heart business. “At Abbott, we are continually looking for new and better ways to address structural heart diseases, and this approval is another step forward in helping people achieve better health.”

For more information on the Amplatzer Amulet LAA Occluder, please visit: http://abbo.tt/Amulet.

The Amplatzer Steerable Delivery Sheath and Amplatzer Amulet LAA Occluder are not approved for use in the U.S.   

Tags: < Innovation

Related Industries

Health

Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas, reinforcing hospital offering and leading Anti-Infectives portfolio

January 25, 2023
Health

Aleksandra Rizo Appointed as CEO of Vividion Therapeutics

January 25, 2023
Health


Philips and Masimo expand partnership to improve telehealth for patients and clinicians around the world

January 19, 2023
Health

Bayer acquires Blackford Analysis Ltd. bolstering the company’s position in digital medical imaging

January 19, 2023
Health

Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies

January 10, 2023
Health

AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline

January 10, 2023

A.P. Moller – Maersk announces new executive leadership team

January 11, 2023

...

Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas, reinforcing hospital offering and leading Anti-Infectives portfolio

January 25, 2023

...

Spark collaborates with Ericsson and Red Hat for 5G Standalone trial

January 26, 2023

...

TotalEnergies EP Canada acquires an additional interest in Fort Hills, ahead of its planned spin-off

January 28, 2023

...

Johnson Controls Acquires Hybrid Energy to Enhance Industrial Heat Pump Portfolio

January 14, 2023

...

Leonardo and Safran partner for AW09 single-engine helicopter propulsion system

January 27, 2023

...

Siemens & Deloitte demonstrate Industry 4.0 innovation at The Smart Factory @ Wichita

January 20, 2023

...

Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies

January 10, 2023

...

GlobalLogic to Open New Digital Engineering Centers in Spain

January 17, 2023

...

With the foundation of the joint venture Cofinity-X, ten partners of the automotive industry will further foster the adoption of the Catena-X network

February 1, 2023

...

Asia Pacific Business Asia Pacific Business Asia Pacific Business

EUROPEAN BUSINESS is a premier source of corporate news, business information and insights across broad spectrum of industries in Europe and worldwide.  We are one of the members of the Business World Network.

RESOURCES

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor # european-biz.com

PARTNERSHIP:     partnership # european-biz.com

HUMAN RESOURCE:     hr # european-biz.com

* (replace # with @)

  • Official Site

Copyright © EUROPEAN-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © EUROPEAN-BIZ.COM All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist